Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.22% of ...

William Blair analyst Andrew Jeffrey reiterated a Buy rating on SoFi Technologies (SOFI – Research Report) on January 18. The company’s shares ...

Investment analysts at William Blair boosted their FY2024 earnings per share (EPS) estimates for shares of Watsco in a ...

On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...

A three-judge panel of the 3rd Circuit Court of Appeals this week reversed an order by a district judge in Pittsburgh affirming Pennsylvania laws that prohibit adults under the age of 21 from ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...

SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the ...

William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...

Biogen proposes acquiring Sage Therapeutics for $7.22 per share, as analysts highlight the strategic value of Zurzuvae's ...